je.st
news
U.S. Food and Drug Administration Approves ABRAXANE in Combination...
2013-09-07 09:04:00| Biotech - Topix.net
Celgene Corporation today announced that the U.S. Food and Drug Administration has approved the Company's supplemental New Drug Application of ABRAXANEA as first-line treatment for patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.
Tags: food
administration
combination
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||